Patents by Inventor Juergen Dolderer

Juergen Dolderer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method of treating colorectal carcinoma
    Patent number: 7915294
    Abstract: A method is disclosed for detecting colorectal carcinoma having at least one HERG potassium ion channel, where at least one HERG potassium channel is detected in a tissue biopsy of the human color or rectum. In addition, a method is disclosed for treating colorectal carcinoma having at least one HERG potassium channel in a patient in need of said treatment, which comprises the step of administering to said patient, a therapeutically effective amount of 4-[1-{2-(6-methyl-2-pyridinyl)ethyl-4-piperidinyl}carbonyl]methane-sulfoanilide 2HCl sufficient to treat the colorectal carcinoma having at least one HERG potassium channel by selectively blockading the HERG potassium channel.
    Type: Grant
    Filed: February 11, 2009
    Date of Patent: March 29, 2011
    Inventor: Juergen Dolderer
  • Diagnostic agent, method for detecting a carcinoma, and means for the treatment thereof
    Patent number: 7598270
    Abstract: A diagnostic agent and a method for detecting a carcinoma are described, where at least one HERG potassium channel is detected in a tissue biopsy of the human colon or rectum. In addition, the use of the antiarrhythmic agent E-4031 for treatment of colorectal carcinoma is described.
    Type: Grant
    Filed: May 30, 2003
    Date of Patent: October 6, 2009
    Inventor: Jürgen Dolderer
  • DIAGNOSTIC AGENT AND METHOD FOR DETECTION OF CANCER AND A MEANS FOR TREATMENT OF SAME
    Publication number: 20090192193
    Abstract: A method is disclosed for detecting colorectal carcinoma having at least one HERG potassium ion channel, where at least one HERG potassium channel is detected in a tissue biopsy of the human color or rectum. In addition, a method is disclosed for treating colorectal carcinoma having at least one HERG potassium channel in a patient in need of said treatment, which comprises the step of administering to said patient, a therapeutically effective amount of 4-[1-{2-(6-methyl-2-pyridinyl)ethyl-4-piperidinyl}carbonyl]methane-sulfoanilide 2HCl sufficient to treat the colorectal carcinoma having at least one HERG potassium channel by selectively blockading the HERG potassium channel.
    Type: Application
    Filed: February 11, 2009
    Publication date: July 30, 2009
    Inventor: JUERGEN DOLDERER